Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts
Clinical Infectious Diseases · 24.12.2025 · 81 (5) · 1008-1014
DOI: 10.1093/cid/ciaf170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 03.04.2025. Verfasst von Beatrice Z Sim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Immunocompromised Host, Invasive Fungal Infections, Metagenomics, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Duke University, NIAID.
Abstract (Originalsprache)
Background
New and minimally invasive tools to aid the diagnosis of invasive fungal diseases (IFD) are urgently needed as the immunocompromised population at highest risk increases. Advancements in molecular technology have rendered new diagnostics more readily available for clinical use.
Methods
This case-control study used prospectively collected archived plasma specimens and data from the Aspergillus Technology Consortium Repository to investigate the diagnostic performance of microbial cell-free DNA (mcfDNA) sequencing as a minimally invasive diagnostic for IFDs in a population of high-risk immunocompromised hosts including hematologic malignancy, stem cell, and solid organ transplants patients. The 2008 Mycoses Study Group/European Organization for the Research and Treatment of Cancer diagnostic criteria served as the gold standard for test performance.
Results
Sixty-five adult subjects with proven or probable IFD and 65 controls without IFD were included. Among IFD episodes Aspergillus was the most common pathogen (70.8%, 46/65), followed by Mucorales (10.8%, 7/65). Overall, sensitivity was 47.7% and specificity was 100%. Sensitivity varied based on disease certainty and pathogen; sensitivity was higher in proven versus probable IFD (60.0% vs 37.1%, respectively) and higher for subjects with invasive mucormycosis (100%) compared with aspergillosis (45.7%).
Conclusions
A positive result by mcfDNA sequencing may reduce the need for invasive sampling in patients with suspected IFD. In this exploratory analysis, its high sensitivity and specificity for invasive mucormycosis suggests it could be useful for early treatment and intervention of this IFD. Future studies should focus on understanding how specific factors impact the sensitivity of mcfDNA sequencing for invasive aspergillosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA.
- Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
- Section of Clinical Microbiology, Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah, USA.
- Division of Infectious Diseases, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Division of Infectious Diseases, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
- Division of Infectious Diseases, Department of Medicine, University of Texas Medical School at Houston, Houston, Texas, USA.
ORCID-Profile: Beatrice Z Sim, Madeleine R Heldman, Kimberly E Hanson, Angela M Caliendo, David Andes, John R Wingard
Förderung
- NIAID NIH HHS
- Duke University
- NIAID
Zitieren
APA
Sim, B. Z., Mah, J. K., Heldman, M. R., Stanly, K. L., Hanson, K. E., Caliendo, A. M., Andes, D., Ostrosky-Zeichner, L., Wingard, J. R., & Alexander, B. D. (2025). Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts. Clinical Infectious Diseases, 81(5), 1008-1014. https://doi.org/10.1093/cid/ciaf170
Vancouver
Sim BZ, Mah JK, Heldman MR, Stanly KL, Hanson KE, Caliendo AM, et al. Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts. Clinical Infectious Diseases. 2025;81(5):1008-1014. doi:10.1093/cid/ciaf170
BibTeX
@article{Sim2025,
author = {Sim, Beatrice Z and Mah, Jordan K and Heldman, Madeleine R and Stanly, Kelly L and Hanson, Kimberly E and Caliendo, Angela M and Andes, David and Ostrosky-Zeichner, Luis and Wingard, John R and Alexander, Barbara D},
title = {Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {81},
number = {5},
pages = {1008--1014},
doi = {10.1093/cid/ciaf170}
}
EUVIMED